Skip to content

R&D at other companies

Celanese Corporation logo
Celanese CorporationCE
$28M-9.7%
Materion logo
MaterionMTRN
$6.16M-5.3%
Eastman Chemical logo
Eastman ChemicalEMN
$60M-10.4%
Element Solutions logo
Element SolutionsESI
$20.2M+27.0%
Hexcel logo
HexcelHXL
$17.8M+29.0%
Dow logo
DowDOW
$181M-9.5%

Other financials

Income statement

See full
Revenue$904.0M-3.4%
Gross profit$210.0M-12.9%
Operating income$129.0M-20.4%
Net income$68.0M-27.7%
EPS (diluted)$1.27-24.9%

Balance sheet

See full
Cash & equivalents$252.0M+18.3%
Total debt$1.0B-18.9%
Total equity$1.6B+9.9%
Total assets$3.9B+3.0%

Cash flow

See full
Operating cash flow$77.0M+5.5%
CapEx$45.0M-37.5%
Free cash flow$32.0M+3,100%

Valuation

See full
Market cap$4.74B-12.8%
Enterprise value$5.52B-15.4%
P/E16.6×+4.1×
P/S1.3×-0.1×

Profitability

See full
Gross margin24.8%-0.1pp
Operating margin15.7%-0.6pp
Net margin8%-3.1pp
FCF margin12.1%+4.0pp

Returns & leverage

See full
Return on equity19%-12.0pp
Debt / equity0.7×-0.2×
Current ratio1.4×-0.5×

Where this comes from

Reported directly by Cabot Corporation in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Cabot Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cabot Corporation's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cabot Corporation's R&D?
Cabot Corporation (CBT) reported R&D of $14M in Q1 2026.
How has Cabot Corporation's R&D changed year-over-year?
Cabot Corporation's R&D decreased by 6.7% year-over-year, from $15M to $14M.
What is the long-term trend for Cabot Corporation's R&D?
Over 4 years (2021 to 2025), Cabot Corporation's R&D has grown at a 1.3% compound annual growth rate (CAGR), from $56M to $59M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.